Forum > Topic Details

To find information about the approval status of a medication like Extra Super P Force in different countries, you can consult several authoritative sources. Extra Super P Force is a combination medication containing sildenafil and dapoxetine, used to treat erectile dysfunction and premature ejaculation. Here are some key sources: National Regulatory Agencies: Each country has a regulatory body responsible for the approval and oversight of medications. United States: The Food and Drug Administration (FDA) provides information on approved drugs. European Union: The European Medicines Agency (EMA) oversees drug approvals. United Kingdom: The Medicines and Healthcare products Regulatory Agency (MHRA) is the regulatory body. Canada: Health Canada is the responsible agency. Australia: Extra Super P Force Therapeutic Goods Administration (TGA) handles drug approvals. Manufacturer Information: The pharmaceutical company that manufactures Extra Super P Force may provide information on its website regarding the approval status in various countries. Pharmaceutical Databases: Websites like Drugs.com, WebMD, and similar databases often provide information on the approval status of medications, though these should be verified with official sources. Healthcare Providers and Pharmacists: Consulting with healthcare professionals can also provide insights into the approval status and availability of Extra Super P Force in specific regions. Official Publications and Notices: Regulatory agencies often publish lists of approved drugs and updates on their websites, which can be a reliable source of information. For specific details, you can visit the websites of the aforementioned regulatory agencies or contact them directly for the most accurate and up-to-date information regarding the approval status of Extra Super P Force in different countries.